NCT07836244

Brief Summary

The goal of this bidirectional observational cohort study is to investigate the longitudinal relationship between neonatal white matter injury (WMI) and the subsequent development of attention-deficit/hyperactivity disorder (ADHD), and to identify early MRI-based markers associated with ADHD-related outcomes. The study includes both retrospective and prospective cohorts to dynamically evaluate the evolution of brain injury, brain development, and behavioral outcomes from infancy to childhood. The main questions it aims to answer are: Are neonatal WMI characteristics associated with the subsequent development of ADHD? Which MRI-derived features, including semi-quantitative WMI assessment, microstructural alterations, and structural disconnection patterns, are associated with ADHD-related outcomes? Participants with neonatal WMI will undergo longitudinal clinical, neurodevelopmental, and behavioral follow-up. Researchers will analyze clinical information and MRI findings to characterize WMI evolution and identify imaging markers associated with ADHD risk. Participants will: undergo brain MRI examinations according to clinical protocols; receive standardized neurodevelopmental and behavioral assessments during follow-up; have MRI-derived measures, including semi-quantitative WMI scores, white matter microstructural features, and structural disconnection measures, analyzed to investigate their associations with ADHD-related outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
348

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 28, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

January 29, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 23, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2025

Completed
1.3 years until next milestone

First Posted

Study publicly available on registry

September 23, 2026

Completed
Last Updated

September 23, 2026

Status Verified

December 1, 2022

Enrollment Period

1.6 years

First QC Date

December 28, 2022

Last Update Submit

September 19, 2026

Conditions

Keywords

NeonatesMulti-modality MRIWhite matter injuryADHDpunctate white matter lesions

Outcome Measures

Primary Outcomes (1)

  • Attention-Deficit/Hyperactivity Disorder (ADHD) Diagnosis

    ADHD diagnosis will be determined according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, combined with standardized behavioral assessment using the Swanson, Nolan, and Pelham (SNAP) questionnaire. The number of participants meeting the diagnostic criteria for ADHD at follow-up will be recorded.

    At 3-5 years of age

Secondary Outcomes (2)

  • Cognitive Developmental Outcome

    During infancy follow-up assessments (6 months to 5 years of age)

  • Motor Developmental Outcome

    During infancy follow-up assessments (6 months to 5 years of age)

Study Arms (2)

White matter injure group

Neonates presented with punctate, linear, or clustered white matter lesions at the center of the semiovale and lateral ventricles, with TIWI hyper-intensive s and with or without T2WI hypointensity.

Control group

No abnormal signals are found on both conventional and diffusion images. SWI and ASL are also considered when necessary.

Eligibility Criteria

Age1 Day+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is derived from a multicenter neonatal and infant clinical and multimodal MRI database established through a national research project. The database includes clinical information and multimodal MRI data collected from multiple clinical centers. This bidirectional observational cohort study includes neonates with white matter injury (WMI) identified on brain MRI and control neonates without apparent abnormalities on routine MRI. Eligible participants will be screened from the existing database, and clinical characteristics, MRI findings, and longitudinal neurobehavioral outcomes will be analyzed to investigate the association between neonatal brain injury patterns and later developmental outcomes.

You may qualify if:

  • Neonates diagnosed with white matter injury (WMI) or neonates without obvious abnormalities on routine MRI examination from the multicenter database.
  • Brain MRI examination performed within 28 days after birth, with gestational age ≤42 weeks at examination.
  • Complete MRI data available, including T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and diffusion tensor imaging (DTI).
  • Complete maternal and pregnancy history information, neonatal demographic characteristics, and clinical information available.

You may not qualify if:

  • Congenital nervous system developmental malformations or suspected genetic or metabolic diseases.
  • Obvious MRI artifacts affecting image evaluation.
  • Inability to complete follow-up neurobehavioral assessments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, China

Location

Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University

Hangzhou, China

Location

Gansu Province Maternity and Child Health Hospital

Lanzhou, China

Location

Qinghai Red Cross Hospital

Qinghai, China

Location

Hebei Children's Hospital

Shijiazhuang, China

Location

Children's Hospital of Soochow University

Suzhou, China

Location

Wuxi Children's Hospital

Wuxi, China

Location

Northwest Women's and Children's Hospital

Xi'an, China

Location

The Second Affiliated Hospital of Shaanxi University of Chinese Medicine

Xianyang, China

Location

MeSH Terms

Conditions

LeukoaraiosisAttention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsAttention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Jian Yang, Ph.D.,M.D.

    First Affiliated Hospital Xi'an Jiaotong University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 28, 2022

First Posted

September 23, 2026

Study Start

January 29, 2023

Primary Completion

August 23, 2024

Study Completion

May 30, 2025

Last Updated

September 23, 2026

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations